Liberty Health Sciences (OTCMKTS:LHSIF) Trading Down 2.2% – Should You Sell?

Shares of Liberty Health Sciences Inc. (OTCMKTS:LHSIF) fell 2.2% on Tuesday . The company traded as low as $1.10 and last traded at $1.1446. 671,400 shares changed hands during trading, a decline of 60% from the average daily volume of 1,668,884 shares. The stock had previously closed at $1.17.

Liberty Health Sciences Stock Down 2.2%

The firm’s 50 day simple moving average is $1.14 and its 200-day simple moving average is $1.14. The company has a market capitalization of $392.01 million, a PE ratio of 38.17 and a beta of 1.70.

Liberty Health Sciences Company Profile

Liberty Health Sciences, trading on the OTC Markets under the symbol LHSIF, is a vertically integrated medical cannabis company headquartered in Florida. The company holds state‐issued Medical Marijuana Treatment Center licenses that authorize cultivation, processing and retail operations within Florida’s regulated medical marijuana program. Its state‐of‐the‐art cultivation facilities feature controlled indoor and greenhouse environments designed to produce consistent, high‐quality flower and derivative products.

Liberty Health Sciences markets its products under the Sunshine Cannabis Co brand, offering a range of cannabis formulations that include dried flower, pre-rolled joints, concentrates, oils, capsules and topical preparations.